Log in or Sign up for Free to view tailored content for your specialty!
Spondyloarthropathies News
Discontinuing biologics in axial spondyloarthritis 'not a good idea'
DESTIN, Fla. — New data on discontinuation or dose reduction of biologic therapies has led to a shifting landscape in axial spondyloarthritis management, according to a speaker at the Congress of Clinical Rheumatology East annual meeting.
FDA approves high-concentration, citrate-free form of interchangeable biosimilar Cyltezo
The FDA has approved a citrate-free, high-concentration formulation of the interchangeable adalimumab biosimilar Cyltezo to treat multiple chronic inflammatory diseases, according to the manufacturer.
Log in or Sign up for Free to view tailored content for your specialty!
Amjevita leads Humira biosimilars in clinician comfort as rheumatologists remain wary
Only half of rheumatologists are “extremely comfortable” prescribing the Humira biosimilar Amjevita, while just 16% can say the same for all other adalimumab biosimilars combined, according to a market analysis from Spherix Global Insights.
Ultrasound differentiates SpA-related enthesitis from mechanical pathology
Ultrasound can differentiate spondyloarthritis-related enthesitis from other entheseal pathologies such as mechanical enthesitis, according to data published in Annals of the Rheumatic Diseases.
Cardiovascular comorbidity risk highest near time of rheumatic disease diagnosis
Among patients with rheumatic diseases, the risk for cardiovascular comorbidity is highest during the period immediately before or after initial diagnosis, according to data published in Seminars in Arthritis and Rheumatism.
No spondyloarthritis screening tools generalizable to all at-risk patients
Screening patients with psoriasis, uveitis or inflammatory bowel disease for spondyloarthritis could improve early diagnosis, but no existing screening tools are generalizable to all who are at risk, according to a scoping review.
IMIDs not tied to adverse pregnancy outcomes overall; lupus, APS linked to preterm birth
Pregnant patients with lupus or antiphospholipid syndrome have a higher risk for preterm birth, although immune-mediated inflammatory diseases in general are “only weakly associated” with adverse pregnancy outcomes, according to data.
VIDEO: ‘Optimally personalize’ care to safely target extraintestinal manifestations of IBD
In a Healio video exclusive, Gil Y. Melmed, MD, MS, highlights certain therapies that should be avoided or included in the management of patients with extraintestinal manifestations of inflammatory bowel disease.
Men with inflammatory joint diseases have more children than those without IJDs
Men with inflammatory joint diseases have more children and are less likely to be childless, compared with those without inflammatory joint diseases, according to data published in the Annals of the Rheumatic Diseases.
Drug costs and nocebo risks: Navigating the Humira ‘biosimilar boom’ 1 year later
A lot can change in a year. But has it?
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read